Status:
COMPLETED
Sarcopenia and Paclitaxel-Induced Neuropathy in Early Stage Breast Cancer (Neuro-Sarc)
Lead Sponsor:
Gazi University
Conditions:
Sarcopenia
Paclitaxel Induced Neuropathy
Eligibility:
FEMALE
18-80 years
Brief Summary
This prospective observational study aims to investigate the relationship between sarcopenia and the development of paclitaxel-induced peripheral neuropathy in patients with early-stage breast cancer....
Detailed Description
This multicenter prospective observational study was designed to evaluate whether baseline sarcopenia is associated with the development and severity of peripheral neuropathy in patients receiving pac...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Histologically confirmed early-stage breast cancer
- Planned to receive neoadjuvant or adjuvant paclitaxel-based chemotherapy
- Patients receiving paclitaxel-carboplatin or paclitaxel-trastuzumab-pertuzumab regimens are also eligible
- Provided written informed consent
Exclusion
- Age \< 18 years
- No pathological diagnosis of breast cancer
- Refusal to participate in the study
- Male patients
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06996548
Start Date
November 1 2024
End Date
May 6 2025
Last Update
December 29 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye), 06170
2
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, Yenimahalle, Turkey (Türkiye), 06200
3
Gazi University
Ankara, Yenimahalle, Turkey (Türkiye), 06560